PharmGKB contains no dosing guidelines for this gene. To report known dosing guidelines, or if you are interested in developing guidelines, click here.
PharmGKB contains no drug labels with pharmacogenomic information for this gene. To report a drug label with PGx, click here.
PharmGKB contains no clinical annotations for this gene. To report clinical variants, click here.
PharmGKB contains no genetic tests for this gene. To report genetic tests, click here.
|Alternate Names:||GTP-binding regulatory protein Gi alpha-2 chain|
|Alternate Symbols: ||GIP|
|PharmGKB Accession Id:||PA24347|
|Cytogenetic Location:||chr3 : p21.31 - p21.31|
|GP mRNA Boundary†:||chr3 : 50273647 - 50296786|
|GP Gene Boundary†:||chr3 : 50263647 - 50299786|
PharmGKB Curated Pathways
Pathways created internally by PharmGKB based primarily on literature evidence.
Beta-agonist/Beta-blocker Pathway, Pharmacodynamics
Simplified pharmacodynamic pathway of drug action on beta 2 adrenergic receptor in a stylized airway cell.
Platelet Aggregation Inhibitor Pathway, Pharmacodynamics
Effects of antiplatelet drugs on platelet aggregation pathway.
Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics
Genes involved in serotonin synthesis, release, reuptake, and in mediation of the antidepressant effect of selective serotonin reuptake inhibitors (SSRI) in human brain.
Links to non-PharmGKB pathways.
Publications related to GNAI2: 1
The following icons indicate that data of a certain type is available:
- DG Dosing Guideline information is available
- DL Drug Label information is available
- CA High-level Clinical Annotation is available
- VA Variant Annotation is available
- VIP VIP information is available
- PW Pathway is available
[ close ]
||Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. The Journal of allergy and clinical immunology. 2006. Johnson Malcolm.|